United States · Bill · S
S. 1015 (104th)
A bill to provide for the liquidation or reliquidation of certain entries of pharmaceutical grade phospholipids.
Introduced
10 July 1995
Last action
10 July 1995 · Introduced
Status
Read twice and referred to the Committee on Finance.
Sponsors
Sen. Helms, Jesse [R-NC]
Subjects
Discovery layer
Source updated
14 January 2025
Summary
Provides for the liquidation or reliquidation at a lower duty rate of certain entries of pharmaceutical grade phospholipids.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 July 1995
Introduced
Sponsor introductory remarks on measure. (CR S9638)
Source: IntroReferral
10 July 1995
Introduced
Introduced in Senate
Source: IntroReferral
10 July 1995
Introduced
Read twice and referred to the Committee on Finance.
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 10 July 1995 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 10 July 1995
Introduced in Senate (PDF)
Introduced in Senate · EN · 10 July 1995
Introduced in Senate
summary · EN · 10 July 1995
Sponsors
- Sen. Helms, Jesse [R-NC] · R · Sponsor
- · ssfi00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/104th-congress/senate-bill/1015
- Open data entity: https://api.congress.gov/v3/bill/104/s/1015
- us · 104-s-1015 · source updated 14 January 2025